Murphy & Mullick Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Murphy & Mullick Capital Management's MRK Position: Q3 2026 in Review
Murphy & Mullick Capital Management increased its Merck (MRK) stake by 3% in Q3 2026, buying an estimated $47.7K and bringing the position to 11,818 shares worth $1.72M. The position accounts for 1.05% of the portfolio, ranked #22.
Murphy & Mullick Capital Management first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 3,953 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Murphy & Mullick Capital Management held 11,818 shares of Merck worth $1.72M as of Q3 2026.
- Murphy & Mullick Capital Management bought 345 Merck shares in Q3 2026, an estimated $47.7K.
- Merck made up 1.05% of Murphy & Mullick Capital Management's portfolio in Q3 2026, its #22 holding.
- Murphy & Mullick Capital Management first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
- 3,953 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Murphy & Mullick Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.